Secondary inflammation

Secondary inflammation is a complex, time-dependent pathological process that occurs following an initial physical or chemical insult, such as traumatic brain injury, spinal cord injury, or ischemic stroke [1, 8]. Unlike the primary injury, which is usually mechanical or immediate, secondary inflammation involves a delayed cascade of biochemical and cellular events characterized by the activation of resident immune cells like microglia, the infiltration of peripheral leukocytes, and the massive release of pro-inflammatory mediators including cytokines, chemokines, and reactive oxygen species [8, 13]. This secondary wave often leads to further tissue damage, neuronal apoptosis, and the expansion of the original lesion, making it a critical window for therapeutic intervention [3, 12]. While it is not a single molecular target, the process is mediated by specific proteins such as the NLRP3 inflammasome, various interleukins, and tumor necrosis factor (TNF) receptors [2, 14]. Pharmacological strategies often focus on inhibiting these specific mediators to limit the spread of damage and improve functional recovery [15, 17]. Monitoring the intensity of this process typically involves tracking systemic or localized biomarkers such as C-reactive protein (CRP) and Interleukin-6 (IL-6) [4, 5].

Other names

Secondary inflammatory responseDelayed inflammatory cascadeReactive inflammationSecondary inflammatory injury

Inhibition of specific molecular mediators (e.g., cytokines, enzymes) and signaling pathways within the inflammatory cascade to prevent secondary tissue damage and promote resolution.